Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-21

FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Alvogen Inc.)

View source ↗

Summary

FDA approved a supplemental application for Testosterone Cypionate from Alvogen Inc., under ANDA207742.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Testosterone cypionate (testosterone cypionate)

Snippet

SUPPL AP for TESTOSTERONE CYPIONATE (TESTOSTERONE CYPIONATE)